Literature DB >> 28419812

Defining Quality in Head and Neck Reconstruction.

Peter M Vila1, Jason T Rich1, Shaun C Desai2.   

Abstract

Microvascular free flap reconstruction has now become the standard of care in the reconstruction of selected head and neck defects. Although uncommon, flap failure is a catastrophic event that results in significant patient morbidity, extended length of hospitalization, and increased cost. However, there is currently no gold standard for measuring the quality of a reconstructive center. Structure and process outcomes have recently been developed, but outcome measures are still lacking. Areas for future research include preoperative nutrition, preoperative flap planning, intraoperative fluid management, appropriate thromboembolism prophylaxis, consistent perioperative antibiotic regimens, skilled ancillary staff, and clear outcome measures for performance measurement.

Entities:  

Keywords:  free tissue flaps; microvascular surgery; performance measure; quality indicator; reconstructive surgery

Mesh:

Year:  2017        PMID: 28419812     DOI: 10.1177/0194599817703937

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  3 in total

1.  Current practices in microvascular reconstruction in otolaryngology-head and neck surgery.

Authors:  Kevin J Kovatch; John E Hanks; Jayne R Stevens; Chaz L Stucken
Journal:  Laryngoscope       Date:  2018-09-08       Impact factor: 3.325

2.  Free Flap Reconstruction of the Head and Neck Region: A Series of 127 Flaps Performed by Otolaryngologists.

Authors:  Bora Başaran; Selin Ünsaler; Mustafa Caner Kesimli; İsmet Aslan
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-07-30

3.  A combination of two regional flaps for the complex reconstruction after head and neck cancer surgery as an alternative approach during the COVID-19 pandemic: A case report.

Authors:  Ana Caruntu; Liliana Moraru; Raluca Monica Comaneanu; Raluca Simona Costache; Titus Alexandru Farcasiu; Cristian Scheau; Daniel Octavian Costache; Constantin Caruntu
Journal:  Exp Ther Med       Date:  2022-04-01       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.